Protara Therapeutics Inc (TARA)
3.10
-0.64
(-17.11%)
USD |
NASDAQ |
May 17, 16:00
3.10
0.00 (0.00%)
After-Hours: 20:00
Protara Therapeutics Shares Outstanding: 20.59M for April 30, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
April 30, 2024 | 20.59M |
April 11, 2024 | 20.58M |
April 10, 2024 | 20.58M |
March 31, 2024 | 11.43M |
March 08, 2024 | 11.43M |
December 31, 2023 | 11.36M |
November 02, 2023 | 11.36M |
November 01, 2023 | 11.36M |
September 30, 2023 | 11.36M |
August 01, 2023 | 11.33M |
June 30, 2023 | 11.31M |
May 01, 2023 | 11.31M |
April 11, 2023 | 11.31M |
March 31, 2023 | 11.31M |
March 03, 2023 | 11.31M |
December 31, 2022 | 11.27M |
October 31, 2022 | 11.27M |
September 30, 2022 | 11.27M |
August 05, 2022 | 11.27M |
June 30, 2022 | 11.26M |
May 02, 2022 | 11.25M |
April 12, 2022 | 11.25M |
March 31, 2022 | 11.25M |
March 04, 2022 | 11.25M |
Date | Value |
---|---|
December 31, 2021 | 11.24M |
November 03, 2021 | 11.24M |
September 30, 2021 | 11.24M |
August 02, 2021 | 11.24M |
June 30, 2021 | 11.23M |
May 05, 2021 | 11.23M |
April 13, 2021 | 11.23M |
March 31, 2021 | 11.23M |
March 09, 2021 | 11.23M |
December 31, 2020 | 11.21M |
December 07, 2020 | 11.21M |
November 10, 2020 | 11.21M |
October 06, 2020 | 11.21M |
September 30, 2020 | 10.52M |
September 24, 2020 | 10.51M |
July 31, 2020 | 5.858M |
June 30, 2020 | 5.843M |
May 12, 2020 | 5.843M |
April 13, 2020 | 5.843M |
March 31, 2020 | 5.843M |
March 19, 2020 | 5.843M |
March 10, 2020 | 5.843M |
January 30, 2020 | 5.843M |
January 10, 2020 | 5.844M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
5.843M
Minimum
Jan 30 2020
20.59M
Maximum
Apr 30 2024
10.81M
Average
11.24M
Median
Shares Outstanding Benchmarks
AngioDynamics Inc | 40.05M |
Regulus Therapeutics Inc | 65.47M |
Bio-Path Holdings Inc | 0.6788M |
Outset Medical Inc | 51.72M |
NovaBay Pharmaceuticals Inc | 37.83M |